EP3826620A4 - Dopaminagonisten enthaltende inhalationszusammensetzungen - Google Patents

Dopaminagonisten enthaltende inhalationszusammensetzungen Download PDF

Info

Publication number
EP3826620A4
EP3826620A4 EP19833638.0A EP19833638A EP3826620A4 EP 3826620 A4 EP3826620 A4 EP 3826620A4 EP 19833638 A EP19833638 A EP 19833638A EP 3826620 A4 EP3826620 A4 EP 3826620A4
Authority
EP
European Patent Office
Prior art keywords
dopamine agonists
inhalation compositions
inhalation
compositions
dopamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19833638.0A
Other languages
English (en)
French (fr)
Other versions
EP3826620A2 (de
Inventor
Ali Turkyilmaz
Irem Yenice
Devrim Celik
Arzu CAYIR
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arven Ilac Sanayi ve Ticaret AS
Original Assignee
Arven Ilac Sanayi ve Ticaret AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arven Ilac Sanayi ve Ticaret AS filed Critical Arven Ilac Sanayi ve Ticaret AS
Publication of EP3826620A2 publication Critical patent/EP3826620A2/de
Publication of EP3826620A4 publication Critical patent/EP3826620A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP19833638.0A 2018-07-12 2019-07-10 Dopaminagonisten enthaltende inhalationszusammensetzungen Withdrawn EP3826620A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR201809930 2018-07-12
PCT/TR2019/050555 WO2020013793A2 (en) 2018-07-12 2019-07-10 Inhalation compositions comprising dopamine agonists

Publications (2)

Publication Number Publication Date
EP3826620A2 EP3826620A2 (de) 2021-06-02
EP3826620A4 true EP3826620A4 (de) 2023-03-08

Family

ID=69142465

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19833638.0A Withdrawn EP3826620A4 (de) 2018-07-12 2019-07-10 Dopaminagonisten enthaltende inhalationszusammensetzungen

Country Status (2)

Country Link
EP (1) EP3826620A4 (de)
WO (1) WO2020013793A2 (de)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002030390A2 (de) * 2000-10-12 2002-04-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur herstellung von pulverformulierungen
US20100018523A1 (en) * 2003-04-14 2010-01-28 John Nicolas Staniforth Composition, device, and method for treating sexual dysfunction via inhalation
US20120321717A1 (en) * 2003-04-14 2012-12-20 Vectura Ltd. Devices and pharmaceutical compositions for enhancing dosing efficiency

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0721394D0 (en) * 2007-10-31 2007-12-12 Vectura Group Plc Compositions for trating parkinson's disease
WO2013109210A1 (en) * 2012-01-16 2013-07-25 Mahmut Bilgic Dry powder formulations comprising budesonide

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002030390A2 (de) * 2000-10-12 2002-04-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur herstellung von pulverformulierungen
US20100018523A1 (en) * 2003-04-14 2010-01-28 John Nicolas Staniforth Composition, device, and method for treating sexual dysfunction via inhalation
US20120321717A1 (en) * 2003-04-14 2012-12-20 Vectura Ltd. Devices and pharmaceutical compositions for enhancing dosing efficiency

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHOUGULE MAHAVIR B ET AL: "Development of dry powder inhalers", RECENT PATENTS ON DRUG DELIVERY & FORMULATION, BENTHAM SCIENCE PUBLISHERS LTD, NL, vol. 1, no. 1, 1 January 2007 (2007-01-01), pages 11 - 21, XP002581085, ISSN: 1872-2113 *

Also Published As

Publication number Publication date
EP3826620A2 (de) 2021-06-02
WO2020013793A2 (en) 2020-01-16
WO2020013793A3 (en) 2020-02-20

Similar Documents

Publication Publication Date Title
EP3953344A4 (de) Glp-ir-agonisten und deren verwendungen
EP3697376B8 (de) Zusammensetzung
EP3622034A4 (de) Beschichtungszusammensetzung(en)
EP3887402A4 (de) Thrombozyten als freisetzungsmittel
EP3886879A4 (de) Thrombozyten als freisetzungsmittel
EP3584364A4 (de) Zusammensetzung
EP3882323A4 (de) Zusammensetzung
EP3586814A4 (de) Härtbare zusammensetzung zur dentalen verwendung
EP3793359A4 (de) Eine antimikrobielle zusammensetzung
EP3217978A4 (de) Zusammensetzungen mit substituiertem benzofurochinolizin und alpha2-adrenergischen agonisten
EP3801538A4 (de) Tlr7-agonisten
EP3682016A4 (de) Formulierungen zur verabreichung von verbindungen
EP3701930A4 (de) Dentale zusammensetzung
EP3897732A4 (de) Cannabinoidhaltige zusammensetzung
EP3895682A4 (de) Dentale zusammensetzung
EP3880628A4 (de) Geopolymerzusammensetzungen
EP3976576A4 (de) Gpr40-agonisten
EP3808785A4 (de) Zusammensetzung
EP3769784A4 (de) Entzündungsunterdrückende zusammensetzung
EP3858322A4 (de) Dentale zusammensetzung
EP3610727A4 (de) Biozidzusammensetzung
EP3826620A4 (de) Dopaminagonisten enthaltende inhalationszusammensetzungen
EP3169736A4 (de) Anpassbare beschichtungszusammensetzung mit fluoriertem copolymer
EP3874951A4 (de) Herbizidzusammensetzung
EP3804720A4 (de) Delamanid enthaltende zusammensetzung

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20210205

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20230203

RIC1 Information provided on ipc code assigned before grant

Ipc: A61M 15/00 20060101ALI20230130BHEP

Ipc: A61K 31/473 20060101ALI20230130BHEP

Ipc: A61P 25/16 20060101ALI20230130BHEP

Ipc: A61K 9/72 20060101AFI20230130BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20230905